Provided by Tiger Trade Technology Pte. Ltd.

The Oncology Institute

2.61
+0.16006.53%
Post-market: 2.620.0100+0.38%19:55 EST
Volume:1.55M
Turnover:3.98M
Market Cap:256.78M
PE:-4.09
High:2.65
Open:2.52
Low:2.47
Close:2.45
52wk High:4.88
52wk Low:0.6015
Shares:98.38M
Float Shares:82.44M
Volume Ratio:0.55
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6386
EPS(LYR):-0.7063
ROE:-4132.17%
ROA:-14.99%
PB:-20.92
PE(LYR):-3.70

Loading ...

The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper

Reuters
·
Jan 13

The Oncology Institute Targets 20% Annual Revenue Growth Through 2028

Reuters
·
Jan 12

the Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

THOMSON REUTERS
·
Jan 12

Oncology Institute Inc: Looking Beyond 2026, Co Is Well Positioned for Continued Expansion

THOMSON REUTERS
·
Jan 12

Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

Dow Jones
·
Jan 12

Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions?

Simply Wall St.
·
Jan 10

Oncology Institute promotes Panda to CIO, Mariano to CPO

TIPRANKS
·
Jan 09

the Oncology Institute Announces Leadership Promotions

THOMSON REUTERS
·
Jan 09

Press Release: The Oncology Institute Announces Leadership Promotions

Dow Jones
·
Jan 09

The Oncology Institute Announces Addition Of Board Member Mark Stolper

Reuters
·
Jan 05

The Oncology Institute Appoints Mark Stolper to Board of Directors

Reuters
·
Jan 05

the Oncology Institute Announces Addition of Board Member Mark Stolper

THOMSON REUTERS
·
Jan 05

the Oncology Institute Announces Resignation of Board Member Gabe Ling

THOMSON REUTERS
·
Dec 01, 2025

Press Release: The Oncology Institute Announces Resignation of Board Member Gabe Ling

Dow Jones
·
Dec 01, 2025

Needham Initiates Coverage on Oncology Institute With Buy Rating, $5 Price Target

MT Newswires Live
·
Nov 25, 2025

Oncology Institute Initiated at Buy by Needham

Dow Jones
·
Nov 25, 2025

Oncology Institute’s Strategic Position and Growth Potential in Value-Based Care Transition

TIPRANKS
·
Nov 25, 2025

Director Mark L. Pacala Reports Disposal of The Oncology Institute Inc. Common Shares

Reuters
·
Nov 21, 2025

Oncology Institute Up Nearly 34%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk

Dow Jones
·
Nov 15, 2025

Oncology Institute Shares Jump 10.6% After Q3 Revenue Jump

THOMSON REUTERS
·
Nov 14, 2025